COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2429.5 | 4 | 0292-0590 | 503.77 | 590.15 | 227 | 55.70 | 0.919 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 811.2 | 4 | 0293-0593 | 414.11 | 594.58 | 329 | 71.01 | 0.820 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 389.6 | 4 | 0294-0594 | 466.09 | 594.47 | 170 | 48.63 | 0.903 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3185.1 | 4 | 0295-0595 | 631.79 | 594.98 | 228 | 56.28 | 0.904 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1601.7 | 4 | 0296-0599 | 330.30 | 599.10 | 240 | 58.18 | 0.891 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1441.7 | 4 | 0297-0600 | 878.35 | 600.18 | 225 | 56.87 | 0.874 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2017.8 | 4 | 0298-0604 | 265.33 | 603.70 | 313 | 65.60 | 0.914 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1248.9 | 4 | 0299-0605 | 521.43 | 604.79 | 295 | 64.18 | 0.900 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 12071.6 | 4 | 0300-0603 | 612.33 | 602.58 | 160 | 46.87 | 0.915 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1614.5 | 4 | 0301-0605 | 933.74 | 605.18 | 223 | 55.94 | 0.895 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 417.2 | 4 | 0302-0606 | 483.26 | 606.68 | 184 | 53.36 | 0.812 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3611.5 | 4 | 0303-0607 | 792.06 | 607.40 | 263 | 59.94 | 0.920 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1724.9 | 4 | 0304-0610 | 238.36 | 610.41 | 227 | 56.28 | 0.900 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2271.0 | 4 | 0305-0612 | 213.73 | 611.44 | 215 | 55.70 | 0.871 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 10321.7 | 4 | 0306-0615 | 619.13 | 615.35 | 176 | 49.11 | 0.917 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 937.0 | 4 | 0307-0622 | 857.02 | 622.48 | 252 | 59.36 | 0.899 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2928.1 | 4 | 0308-0620 | 180.51 | 620.54 | 198 | 53.11 | 0.882 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 816.5 | 4 | 0309-0621 | 647.58 | 621.74 | 256 | 60.18 | 0.888 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1022.6 | 4 | 0310-0626 | 931.96 | 626.09 | 277 | 71.60 | 0.679 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2965.2 | 4 | 0311-0627 | 369.29 | 627.77 | 272 | 62.18 | 0.884 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4936.5 | 4 | 0312-0628 | 240.10 | 627.52 | 191 | 51.11 | 0.919 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1901.9 | 4 | 0313-0631 | 112.43 | 631.22 | 295 | 62.77 | 0.941 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3469.1 | 4 | 0314-0631 | 594.04 | 631.05 | 250 | 59.36 | 0.892 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1326.8 | 4 | 0315-0634 | 396.37 | 634.05 | 245 | 61.60 | 0.811 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1856.3 | 4 | 0316-0636 | 439.91 | 636.09 | 375 | 71.60 | 0.919 |